Literature DB >> 11737231

A noninvasive method to collect nasally exhaled air condensate in humans of all ages.

M Griese1, P Latzin, J Beck.   

Abstract

BACKGROUND: The analysis of exhaled breath condensate may provide valuable insights into inflammatory and other metabolic processes of the lungs. However, its collection by active exhalation with conventional methods is cumbersome, demands a substantial level of co-operation with high motivation and is very difficult or impossible in children younger than about 4-6 years or in the elderly. A comfortable, noninvasive and efficient method is desirable. DESIGN AND PATIENTS: For collection a high-performance pump connected to a cold trap and nasal prongs were used. The volume of the condensate collected was assessed in 141 children of all ages and five adults. As an example for a low molecular component, H2O2 a marker of oxidative stress, was determined fluorometrically.
RESULTS: On average, in healthy children from 4 weeks to 18 years of age, 84.0 (79.4, 87.3) microL min(-1) of nasally exhaled air condensate were collected. The volume obtained was about 45% less in 1-6-year-old children, increased linearly with collection time, and averaged about 20-30% of the exhaled water vapour. The concentration of H2O2 in the healthy children was 0.49 (0.48, 0.61) microM and did not depend on age, the time of the day, family, or personal history of atopy and sex.
CONCLUSIONS: The method described is generally applicable, comfortable, noninvasive, safe and efficient and allows the collection of nasally exhaled air condensate for the evaluation of metabolic processes of the lungs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737231     DOI: 10.1046/j.1365-2362.2001.00875.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

Review 1.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Safety and success of exhaled breath condensate collection in asthma.

Authors:  E Baraldi; L Ghiro; V Piovan; S Carraro; F Zacchello; S Zanconato
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

3.  Inhaled corticosteroids do not reduce initial high activity of matrix metalloproteinase (MMP)-9 in exhaled breath condensates of children with asthma exacerbation: a proof of concept study.

Authors:  Katarzyna Grzela; Wioletta Zagórska; Alicja Krejner; Aleksandra Banaszkiewicz; Małgorzata Litwiniuk; Marek Kulus; Tomasz Grzela
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.